15/11/2023 - Institutional news
Evidence shows an annual loss of 34.6 million life-years globally due to suicide. In response to this, globally renowned institutions specialized in mental health and suicide research, in collaboration with experts in bioinformatics, have launched PERMANENS, a pioneering European research initiative. The PERMANENS research project is dedicated to create a medical software prototype that supports clinicians in delivering personalized assessments and care to patients arriving at the emergency department with an elevated risk of self-harm or suicide. This precision medicine software will harness the power of artificial intelligence to provide more accurate risk assessments and access to evidence-based information, enabling the identification of effective treatment options tailored to each patient's unique needs and risk profile.
10/11/2023 - Institutional news
The 2023 edition of the Scientific Retreat of the Hospital del Mar Research Institute was special. This annual meeting to review the highlights of the year at the institution also served to celebrate its 75th anniversary, making it the oldest active public research center in Spain. A benchmark facility in the field of biomedical research that looks to the future. The event was opened by Dr. Olga Pané, manager of the Hospital del Mar, who addressed the researchers, telling them to "make research a beacon of hope for patients and professionals, and a feat of society, which is materialized in our centers". In turn, the director of the Hospital del Mar Research Institute, Dr. Joaquín Arribas, wanted to emphasize that in the last twelve months, "our researchers, from group leaders to trainees, have managed to improve both the impact of publications and the attraction of competitive resources, as well as the translation to society".
Més informació "Scientific Retreat 2023, 75 years doing research"
09/11/2023 - Institutional news
The Hospital del Mar Research Institute will receive 1.5 million euros in funding from the 2022 La Marató de TV3 and Catalunya Ràdio. These funds will be distributed among four projects led by researchers at the institute in the field of cardiovascular health. Dr. Montse Fitó, coordinator of the Cardiovascular Risk and Nutrition Research Group, leads a project that will analyze the role of microRNA molecules in high-density lipoproteins (HDL) in the incidence of coronary heart disease, analyzing possible personalized treatment strategies for atherosclerosis. The Hospital de la Santa Creu i Sant Pau Research Institute, the Catalan Institute of Nanoscience and Nanotechnology, and the University of Valencia will participate. They will receive funding of almost 400,000 euros.
The Lancet Public Health journal has published the results of one of the largest and most up-to-date studies worldwide to evaluate the point prevalence of clinically relevant depressive symptoms.
03/11/2023 - General information
The award was given to a study presented by Dr. Joan Jiménez Balado from the Neurovascular Research Group at the Hospital del Mar Research Institute. The study titled "DNA-Methylation and Stroke Prognosis: an Epigenome-wide Association Study," presented by Dr. Joan Jiménez Balado, received the award for Best Communication at the 29th edition of the Stroke Genetics Workshop organized by the International Stroke Genetics Consortium in Boston, United States, from October 12 to 14.
Més informació "Award for Best Communication at the Stroke Genetics Workshop"
02/11/2023 - General information
On Monday, October 30th, the Anti-Doping Laboratory of Catalonia received a visit from Catalan sports authorities: Mrs. Anna Caula Paretas, Secretary General of Sports and Physical Activity; Mr. Aleix Villatoro Oliver, Director of the Catalan Sports Council (CCE); and Dr. Daniel Brotons Cuixart, Head of the Sports and Health Unit of the CCE. The Laboratory is one of the 30 laboratories accredited worldwide by the World Anti-Doping Agency (WADA) to analyze samples from athletes. The visit showcased its complexity, as it has to meet stringent technical and quality requirements imposed by WADA to maintain accreditation.
Més informació "Visits by Catalan Sports Authorities to the Anti-Doping Laboratory of Catalonia"
A study involving the Hospital del Mar Research Institute, the Vall d'Hebron Institut d'Oncologia, IDIBELL, and the Institut Català d'Oncologia suggests that combining chemotherapy with drugs that can inhibit two cell signaling pathways involved in tumor progression may aid in treatment. The research has analyzed the interaction of the protein IKKα with these pathways, known for their ability to promote the proliferation of tumor cells. This combination has the advantage of reducing treatment toxicity. The study opens the door to new approaches for tumors with the presence of this protein. It is published in the EMBO Journal.
Més informació "A possible new combination of treatments to combat cancer"
24/10/2023 - Events
As some of you already know, this year the IMIM (now the Hospital del Mar Research Institute) is 75 years old. To commemorate this anniversary, different activities have been programmed, such as the exhibition on the history of the institution that could be visited in the Paseo Marítimo this summer. Continuing with the celebrations, the Scientific Retreat 2023 will take place on 8 November in the PRBB Auditorium. In this edition, in addition to the usual scientific presentations, the event will include the participation of the former directors of the institution, in a round table moderated by Jessica Mouzo, journalist specialised in health and science of the newspaper "El País".
17/10/2023 - Institutional news
The 2023 call of the new CaixaImpulse Innovation program will award 3.3 million euros to 29 biomedical research projects, 15 of which come from Catalan research centers. The aim is to contribute to bringing research results to society and the market, fostering the creation of new products, services and companies related to life sciences and health. The two selected projects focus on developing a new sampling system to facilitate early diagnosis of pancreatic cancer and a new immunotherapy treatment for breast cancer. This initiative offers the selected entrepreneurial scientists financial support and accompaniment through individualized mentoring and training, in collaboration with Caixa Capital Risc and in partnership with the Fundação para a Ciência e a Tecnologia (FCT), of the Portuguese Ministry of Science, Technology and Higher Education, which is funding two projects in this call.
11/10/2023 - Institutional news
The prizes were awarded at the SEOM congress held in Barcelona at the end of September. The doctoral thesis of Dr. Pedro Rocha, assistant doctor at the Oncology Department of the Hospital del Mar and researcher at the Hospital del Mar Research Institute, has received one of the five grants awarded by the Spanish Society of Medical Oncology (SEOM) to doctoral theses by young researchers. The award ceremony took place on 22 September during the congress of the organisation.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact